[1] |
SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
doi: 10.3322/caac.21660
|
[2] |
MCINNES R R, WILLARD H F, NUSSBAUM R L. Thompson & thompson genetics in medicine[M]. 8th ed. Elsevier, 2016.
|
[3] |
LU G H. Genetic counseling for hereditary tumors[M]. Beijing: Peking University Medical Press, 2021.
|
[4] |
KONSTANTOPOULOU I, PERTESI M, FOSTIRA F, et al. Hereditary cancer predisposition syndromes and preimplantation genetic diagnosis: where are we now?[J]. J BUON, 2009, 14(Suppl 1): S187-S192.
|
[5] |
LAMMENS C, BLEIKER E, AARONSON N, et al. Attitude towards pre-implantation genetic diagnosis for hereditary cancer[J]. Fam Cancer, 2009, 8(4): 457-464.
doi: 10.1007/s10689-009-9265-5
pmid: 19642022
|
[6] |
LØSSL K, BENTZEN J G, PETERSEN M R, et al. Preimplantation genetic testing[J]. Ugeskr Laeger, 2021, 183(48): V04210378.
|
[7] |
QUINN G P, VADAPARAMPIL S T. Reproductive health and cancer in adolescents and young adults[M]. Dordrecht: Springer Netherlands, 2012.
|
[8] |
NISHISHO I, NAKAMURA Y, MIYOSHI Y, et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients[J]. Science, 1991, 253(5020): 665-669.
doi: 10.1126/science.1651563
pmid: 1651563
|
[9] |
LANG D, CIOMBOR K K. Diagnosis and management of rectal cancer in patients younger than 50 years: rising global incidence and unique challenges[J]. J Natl Compr Canc Netw, 2022, 20(10): 1169-1175.
doi: 10.6004/jnccn.2022.7056
|
[10] |
葛赛, 王晰程. 家族性腺瘤性息肉病的诊疗进展[J]. 肿瘤综合治疗电子杂志, 2022, 8(1): 107-112.
|
[11] |
GE S, W X C. Progress in diagnosis and treatment of familial adenomatous polyposis[J]. Electron J Compr Cancer Treat, 2022, 8(1): 107-112.
|
[12] |
PAVELKA J C, LI A J, KARLAN B Y. Hereditary ovarian cancer: assessing risk and prevention strategies[J]. Obstet Gynecol Clin North Am, 2007, 34(4): 651-665, vii-viii.
doi: 10.1016/j.ogc.2007.09.005
|
[13] |
HALL J M, LEE M K, NEWMAN B, et al. Linkage of early-onset familial breast cancer to chromosome 17q21[J]. Science, 1990, 250(4988): 1684-1689.
pmid: 2270482
|
[14] |
TIWARI R, SINGH A K. Neurofibromatosis type 2[M]. Treasure Island (FL): StatPearls Publishing, 2022.
|
[15] |
HAMPEL H, FRANKEL W L, MARTIN E, et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer)[J]. N Engl J Med, 2005, 352(18): 1851-1860.
doi: 10.1056/NEJMoa043146
|
[16] |
谢天赐, 徐向上. 林奇综合征发生发展的研究进展[J]. 现代肿瘤医学, 2022, 30(6): 1102-1108.
|
[17] |
XIE T C, XU X S. Research progress on the occurrence and development of Lynch syndrome[J]. J Mod Oncol, 2022, 30(6): 1102-1108.
|
[18] |
FABIAN I D, ONADIM Z, KARAA E, et al. The management of retinoblastoma[J]. Oncogene, 2018, 37(12): 1551-1560.
doi: 10.1038/s41388-017-0050-x
pmid: 29321667
|
[19] |
MCDONNELL J E, GILD M L, CLIFTON-BLIGH R J, et al. Multiple endocrine neoplasia: an update[J]. Intern Med J, 2019, 49(8): 954-961.
doi: 10.1111/imj.14394
pmid: 31387156
|
[20] |
SINGH G, MULJI N J, JIALAL I. Multiple endocrine neoplasia type 1[M]. Treasure Island (FL): StatPearls Publishing, 2022.
|
[21] |
ESHRE PGT CONSORTIUM STEERING COMMITTEE, CARVALHO F, COONEN E, et al. ESHRE PGT consortium good practice recommendations for the organisation of PGT[J]. Hum Reprod Open, 2020, 2020(3): hoaa021.
doi: 10.1093/hropen/hoaa021
|
[22] |
ESHRE PGT-SR/PGT-A WORKING GROUP, COONEN E, RUBIO C, et al. ESHRE PGT Consortium good practice recommendations for the detection of structural and numerical chromosomal aberrations[J]. Hum Reprod Open, 2020, 2020(3): hoaa017.
doi: 10.1093/hropen/hoaa017
|
[23] |
ESHRE PGT-M WORKING GROUP, CARVALHO F, MOUTOU C, et al. ESHRE PGT Consortium good practice recommendations for the detection of monogenic disorders[J]. Hum Reprod Open, 2020, 2020(3): hoaa018.
doi: 10.1093/hropen/hoaa018
|
[24] |
中国医师协会生殖医学专业委员会,中国医师协会医学遗传医师分会. 单基因病胚胎着床前遗传学检测专家共识[J]. 中华生殖与避孕杂志, 2021, 41(6): 477-485.
|
[25] |
Reproductive Medicine Professional Committee of Chinese Medical Doctor Association, Medical Geneticist Branch of Chinese Medical Doctor Association. Expert consensus on preimplantation genetic testing of monogenic diseases[J]. Chin J Reprod Contracept, 2021, 41(6): 477-485.
|
[26] |
SCIORIO R, DATTILO M. PGT-A preimplantation genetic testing for aneuploidies and embryo selection in routine ART cycles: time to step back?[J]. Clin Genet, 2020, 98(2): 107-115.
doi: 10.1111/cge.13732
pmid: 32141057
|
[27] |
SOMIGLIANA E, COSTANTINI M P, FILIPPI F, et al. Fertility counseling in women with hereditary cancer syndromes[J]. Crit Rev Oncol Hematol, 2022, 171: 103604.
doi: 10.1016/j.critrevonc.2022.103604
|
[28] |
VOLOZONOKA L, MISKOVA A, GAILITE L. Whole genome amplification in preimplantation genetic testing in the era of massively parallel sequencing[J]. Int J Mol Sci, 2022, 23(9): 4819.
doi: 10.3390/ijms23094819
|
[29] |
CHEN D J, XU Y, DING C H, et al. The inconsistency between two major aneuploidy-screening platforms—single-nucleotide polymorphism array and next-generation sequencing—in the detection of embryo mosaicism[J]. BMC Genom, 2022, 23: 62.
doi: 10.1186/s12864-022-08294-1
|
[30] |
VAN MONTFOORT A, CARVALHO F, COONEN E, et al. ESHRE PGT Consortium data collection XIX-XX: PGT analyses from 2016 to 2017[J]. Hum Reprod Open, 2021, 2021(3): hoab024.
doi: 10.1093/hropen/hoab024
|
[31] |
VUKOVI\U0107 P, PECCATORI F A, MASSAROTTI C, et al. Preimplantation genetic testing for carriers of BRCA1/2 pathogenic variants[J]. Crit Rev Oncol Hematol, 2021, 157: 103201.
doi: 10.1016/j.critrevonc.2020.103201
|
[32] |
AO A, WELLS D, HANDYSIDE A H, et al. Preimplantation genetic diagnosis of inherited cancer: familial adenomatous polyposis coli[J]. J Assist Reprod Genet, 1998, 15(3): 140-144.
doi: 10.1023/A:1023008921386
|
[33] |
FOUKS Y, SHEIMAN V, GOAZ S, et al. Fertility preservation and PGT-M in women with familial adenomatous polyposis-associated desmoid tumours[J]. Reprod Biomed Online, 2021, 43(4): 637-644.
doi: 10.1016/j.rbmo.2021.07.010
pmid: 34429254
|
[34] |
DAVIS T, SONG B, CRAM D S. Preimplantation genetic diagnosis of familial adenomatous polyposis[J]. Reprod Biomed Online, 2006, 13(5): 707-711.
pmid: 17169185
|
[35] |
JASPER M J, LIEBELT J, HUSSEY N D. Preimplantation genetic diagnosis for BRCA1 exon 13 duplication mutation using linked polymorphic markers resulting in a live birth[J]. Prenat Diagn, 2008, 28(4): 292-298.
doi: 10.1002/pd.1925
|
[36] |
MOR P, BRENNENSTUHL S, METCALFE K A. Uptake of preimplantation genetic diagnosis in female BRCA1 and BRCA2 mutation carriers[J]. J Genet Couns, 2018, 27(6): 1386-1394.
doi: 10.1007/s10897-018-0264-2
|
[37] |
LIPTON J H, ZARGAR M, WARNER E, et al. Cost effectiveness of in vitro fertilisation and preimplantation genetic testing to prevent transmission of BRCA1/2 mutations[J]. Hum Reprod, 2020, 35(2): 434-445.
doi: 10.1093/humrep/dez203
|
[38] |
MICHAAN N, LESHNO M, COHEN Y, et al. Preimplantation genetic testing for BRCA gene mutation carriers: a cost effectiveness analysis[J]. Reprod Biol Endocrinol, 2021, 19(1): 153.
doi: 10.1186/s12958-021-00827-9
|
[39] |
HUGHES T, BRACEWELL-MILNES T, SASO S, et al. A review on the motivations, decision-making factors, attitudes and experiences of couples using pre-implantation genetic testing for inherited conditions[J]. Hum Reprod Update, 2021, 27(5): 944-966.
doi: 10.1093/humupd/dmab013
pmid: 33969393
|
[40] |
XU X Q, SONG R F, HU K Y, et al. Multidisciplinary management for Peutz-Jeghers syndrome and prevention of vertical transmission to offspring using preimplantation genetic testing[J]. Orphanet J Rare Dis, 2022, 17(1): 64.
doi: 10.1186/s13023-022-02221-z
pmid: 35189935
|
[41] |
OFFIT K, KOHUT K, CLAGETT B, et al. Cancer genetic testing and assisted reproduction[J]. J Clin Oncol, 2006, 24(29): 4775-4782.
pmid: 16840542
|
[42] |
VERLINSKY Y, RECHITSKY S, VERLINSKY O, et al. Preimplantation diagnosis for p53 tumour suppressor gene mutations[J]. Reproductive Biomed Online, 2001, 2(2): 102-105.
doi: 10.1016/S1472-6483(10)62233-X
|
[43] |
DAINA G, RAMOS L, OBRADORS A, et al. First successful double-factor PGD for Lynch syndrome: monogenic analysis and comprehensive aneuploidy screening[J]. Clin Genet, 2013, 84(1): 70-73.
doi: 10.1111/cge.12025
pmid: 22998423
|
[44] |
KULKARNI A, KILBY M D. Prenatal diagnosis and pre-implantation genetic diagnosis for cancer susceptibility conditions[J]. BJOG, 2022, 129(5): 760.
doi: 10.1111/1471-0528.16785
|
[45] |
黄荷凤, 乔杰, 刘嘉茵, 等. 胚胎植入前遗传学诊断/筛查技术专家共识[J]. 中华医学遗传学杂志, 2018, 35(2): 151-155.
|
[46] |
HUANG H F, QIAO J, LIU J Y, et al. Expert consensus on preimplantation genetic diagnosis/screening techniques[J]. Chin J Med Genet, 2018, 35(2): 151-155.
|
[47] |
HUANG C Y, ZHENG B, CHEN L J, et al. The clinical application of single-sperm-based single-nucleotide polymorphism haplotyping for PGT of patients with genetic diseases[J]. Reproductive Biomed Online, 2022, 44(1): 63-71.
doi: 10.1016/j.rbmo.2021.09.008
|